Sofie
VA - DullesPharmaceutical
Focus: Sofie is a specialized radiopharmaceutical company focused on PET imaging, radiochemical synthesis, and radiopharma probes targeting oncology, rare diseases, and infectious diseases. The company operates from Dulles, VA with a lean, focused pipeline and marketed diagnostic agents.
Profile data last refreshed 5h ago · AI intelligence enriched 3w ago
Open Jobs
8+75 this month
Hot — 83 jobs added in 30d
Net +75 (83 new, 8 removed). Aggressive expansion phase.
Should You Work at Sofie?
AI assessmentSofie offers a differentiated career in radiopharmaceuticals with real clinical pipeline momentum, but career growth and financial stability depend on undisclosed company size and funding trajectory.
Why Work Here
- Deep expertise in cutting-edge radiopharmaceutical and PET imaging technology—a niche with high technical barriers and growing clinical demand
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
AMMONIA N-13
Stable
Post-LOE
Established diagnostic radiopharmaceutical for myocardial PET imaging; post-LOE generic status limits growth potential.
FLUDEOXYGLUCOSE F-18
Help build intelligence for Sofie
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.